NCT06940414Recruiting
Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community
Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in a Community-Based Primary Care Setting
Source: ClinicalTrials.gov · Last updated 11 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this observational study is to investigate the prevalence and risk factors of hyperkalemia in community-based non-dialysis chronic kidney disease (CKD) patients. The main questions it aims to answer are: 1. What is the prevalence of hyperkalemia in non-dialysis CKD patients in a primary care setting? 2. What are the key risk factors influencing the occurrence of hyperkalemia in this population? Researchers will collect clinical and demographic data from participants across 18 community health centers and use both point-of-care testing (POCT) and laboratory-based methods to measure serum potassium levels and related parameters. Participants will: 1. Provide blood samples for POCT and laboratory testing. 2. Participate in interviews or questionnaires to gather clinical and lifestyle information. The findings will be used to construct a risk prediction model for hyperkalemia, aiming to optimize screening pathways and improve disease management strategies in primary care.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1890 (estimated)
- First submitted
- 11 Apr 2025
- Start date
- 28 Apr 2025
- Primary completion date
- 31 Jul 2025
- Lead sponsor
- Xiujuan Zang
- Diseases
- Chronic kidney disease
- NCT number
- NCT06940414
What you commit to
- Study type: Observational
- Planned participants: 1890
- From 28 Apr 2025 to the primary completion date, 31 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have started renal replacement therapy.
Other illness
- Patients in the unstable phase of acute cardiovascular or cerebrovascular diseases (e.g., acute cerebral infarction, cerebral hemorrhage, or acute coronary syndrome).
- Other conditions deemed unsuitable for participation in this clinical trial by the investigator.
Other
- Patients in the unstable phase of severe acute diabetic complications (e.g., diabetic ketoacidosis or hyperosmolar hyperglycemic coma).
- Patients currently in the acute kidney injury (AKI) stage.
- Pregnant or breastfeeding women.
- Patients currently participating in or who have participated in other clinical trials within the past six months.
- Patients unable to understand verbal or written instructions, including informed consent content.
- Patients unable to cooperate with the study procedures.
Who the study is looking for
- Aged 18 years or older with stable vital signs, specifically defined as:
- Body temperature: 36.0°C-38.0°C;
- Pulse: 50-120 beats/min;
- Respiratory rate: 10-24 breaths/min;
- Blood pressure: Systolic blood pressure ≥90 mmHg and diastolic blood pressure ≥60 mmHg.
- Willing to participate in the study and sign the informed consent form.
- Hematocrit (Hct) level between 25% and 60%.
- Confirmed diagnosis of chronic kidney disease (CKD).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.